Xarelto Federal Suit Filed in West Virginia
A woman in West Virginia has filed a suit in federal court after suffering a gastrointestinal bleed after taking Xarelto. The suit, which claims that the pharmaceutical companies Janssen and Bayer knew or should have known of the increased risks for bleeding as a result of the use of Xarelto.
Xarelto is an oral anticoagulant that was designed to reduce the risk of suffering a stroke and systemic embolism in patients who suffer from non-valvular atrial fibrillation. It is now one of the most common causes for personal injury claims in the United States.
The woman, Nova Rose, and her husband, William, claim that the two pharmaceutical companies ignored multiple studies that indicated the increased risk of gastrointestinal bleeding as a result of the use of Xarelto.
The December 23rd complaint states that the Institute for Safe Medication Practices noted, even during the approval process, that “FDA reviewers also questioned the dosing scheme as it caused peaks and troughs in blood levels.”
Xarleto has caused wide concern as it lacks an antidote, unlike another popular anticoagulant, Warfarin. Lacking an antidote, the event of a hemorrhagic complication contains no reversible agent, according to the suit.
Also included in the suit are allegations of multiple violations including: negligence, fraudulent misrepresentation, fraudulent concealment, negligent misrepresentation, fraud and deceit, and violation of the West Virginia Consumer Credit & Protection Act.
Do not be surprised to see more and more of these filings come to the forefront of legal news. Sadly, the Roses are not the only ones who have experienced serious adverse events at the hands of Xarelto use, and the number of personal injury filings will continue to rise as more and more cases become available.